Anti-Cancer Agent, Tarceva® Condition for Approval (All Patients Surveillance) Partially Removed in Japan for “Nonresectable Recurrent and Advanced Non-small Cell Lung Cancer which is Aggravated Following Chemotherapy”
Feb 07, 2012
Anti-Cancer Agent, Tarceva® Condition for Approval (All Patients Surveillance) Partially Removed in Japan for “Nonresectable Recurrent and Advanced Non-small Cell Lung Cancer which is Aggravated Following Chemotherapy”
Anti-Cancer Agent, Tarceva® Condition for Approval (All Patients Surveillance) Partially Removed in Japan for “Nonresectable Recurrent and Advanced Non-small Cell Lung Cancer which is Aggravated Following Chemotherapy”
